Renowned clinician and researcher strengthens Convergent Dental's clinical foundation through Solea research and innovation.

WALTHAM, Mass., Feb. 10, 2026 /PRNewswire-PRWeb/ -- Convergent Dental, the power behind the Solea® All-Tissue Dental Laser, today announced the appointment of German O. Gallucci, DMD, PhD, Professor of Restorative Dentistry at Harvard School of Dental Medicine, to its Clinical Advisory Board. Gallucci is an internationally recognized leader in prosthodontics, implant dentistry, restorative dentistry, and digital workflows, with a career spanning clinical care, research, and education.

Gallucci's research in applied digital dental technologies, fixed prosthodontics, and implant dentistry has been published in leading peer-reviewed international journals. He serves on multiple editorial boards and is a Fellow of the International Team for Implantology (ITI), as well as an active member of the Academy of Osseointegration and the European Academy of Osseointegration.

Gallucci has initiated clinical research using the Solea dental laser, evaluating its interaction with enamel and dentin across varying power settings and exposure times, and comparing laser-etched bonding strength with conventional acid-etching techniques. His work contributes to a growing body of evidence supporting laser-based approaches in restorative dentistry.

"Solea represents a meaningful advancement in how dentistry can be practiced—bringing together precision, efficiency, and an improved experience for both patients and clinicians," said Gallucci. "Solea dentistry has the potential to define a new way of doing dentistry, effectively establishing a new discipline within operative dentistry."

"Dr. Gallucci brings a rare combination of clinical insight, research rigor, and hands-on experience with Solea," said Robert L. Gershon, CEO of Convergent Dental. "His evidence-based perspective will help advance clinical applications and inform our long-term innovation strategy as we continue to expand the impact of Solea."

The Convergent Dental Clinical Advisory Board was established to support the continued adoption and evolution of Solea technology. As a board member, Gallucci will collaborate with fellow advisors to help guide clinical protocols, educational initiatives, and future research priorities.

About Convergent Dental

Convergent Dental, Inc. (www.convergentdental.com) is a privately owned dental equipment and technology company. The Company's flagship product, Solea®, is the only CO2 laser to be cleared by the FDA for all-tissue indications and delivers an anesthesia-free, blood-free, suture-free experience that dentists and patients can rely on.[1] Solea® enables dentists to elevate their practices through improved efficiency, patient experience, clinical effectiveness, and procedural expansion.[2]

1. Based on report of 1000 procedures performed by Solea users. Documentation on file.

2. Based on 2022 Annual Survey of Solea users. Documentation on file.

Media Contact

Caitlin D'Entremont, Convergent Dental, 1 5085005656, cdentremont@convergentdental.com, https://www.convergentdental.com/ 

Twitter, LinkedIn

View original content to download multimedia:https://www.prweb.com/releases/convergent-dental-appoints-german-o-gallucci-dmd-phd-professor-of-restorative-dentistry-at-harvard-school-of-dental-medicine-to-clinical-advisory-board-302682155.html

SOURCE Convergent Dental